Treatment options for advanced pancreatic neuroendocrine tumors: What is on the horizon?

Keyphrases

• Treatment Options 100%
• Pancreatic Neuroendocrine Tumors (pNETs) 100%
• Resection 50%
• Cytotoxic Agents 50%
• Ablation 50%
• Antiangiogenic 50%
• Downstream Effectors 50%
• Sunitinib 50%
• Everolimus 50%
• Systemic Therapy 50%
• Tumor Patients 50%
• Tumor Control 50%
• Liver Metastasis 50%
• Tyrosine Kinase Inhibitor 50%
• PI3K-AKT-mTOR Pathway 50%
• Somatostatin Analogs 50%
• Embolization 50%
• Symptom Control 50%
• Pancreatic Tumor 50%
• Peptide Receptor Radionuclide Therapy 50%
• Metastatic Pancreatic Tumor 50%
• Tumor Survival 50%
• Metastasis-directed Therapy 50%
• Advanced or Metastatic 50%

Medicine and Dentistry

• Pancreas Islet Cell Tumor 100%
• Pancreas Tumor 100%
• Treatment Option 100%
• Neoplasm 50%
• Liver Metastasis 50%
• Sunitinib 50%
• Everolimus 50%
• Systemic Therapy 50%
• Radionuclide Therapy 50%
• Tyrosine-Kinase Inhibitor 50%
• Embolization 50%
• Antiangiogenic 50%
• Mammalian Target of Rapamycin 50%
• Somatostatin Derivative 50%
• Protein Kinase B 50%
• Peptide Receptor 50%
• Cytotoxic Agent 50%